Rikoon Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $2.99M | Buy |
47,050
+47
| +0.1% | +$2.99K | 0.8% | 29 |
|
|
2020
Q4 | $2.94M | Buy |
47,003
+1
| +0% | +$63 | 0.82% | 30 |
|
|
2020
Q3 | $2.83M | Sell |
47,002
-231
| -0.5% | -$13.9K | 0.88% | 28 |
|
|
2020
Q2 | $2.78M | Sell |
47,233
-947
| -2% | -$55.7K | 0.93% | 27 |
|
|
2020
Q1 | $2.69M | Buy |
48,180
+356
| +0.7% | +$19.8K | 1.11% | 22 |
|
|
2019
Q4 | $3.07M | Buy |
47,824
+2,186
| +5% | +$140K | 1.06% | 25 |
|
|
2019
Q3 | $2.31M | Buy |
45,638
+400
| +0.9% | +$20.3K | 0.86% | 33 |
|
|
2019
Q2 | $2.05M | Sell |
45,238
-150
| -0.3% | -$6.8K | 0.76% | 35 |
|
|
2019
Q1 | $2.17M | Sell |
45,388
-700
| -2% | -$33.4K | 0.81% | 31 |
|
|
2018
Q4 | $2.4M | Hold |
46,088
| – | – | 0.99% | 24 |
|
|
2018
Q3 | $2.86M | Sell |
46,088
-104
| -0.2% | -$6.46K | 1.01% | 23 |
|
|
2018
Q2 | $2.56M | Buy |
46,192
+317
| +0.7% | +$17.5K | 0.98% | 27 |
|
|
2018
Q1 | $2.84M | Buy |
45,875
+4,380
| +11% | +$272K | 1.15% | 24 |
|
|
2017
Q4 | $2.54M | Buy |
41,495
+454
| +1% | +$27.8K | 1.05% | 27 |
|
|
2017
Q3 | $2.62M | Buy |
41,041
+431
| +1% | +$27.5K | 1.13% | 25 |
|
|
2017
Q2 | $2.26M | Buy |
40,610
+2
| +0% | +$111 | 1% | 29 |
|
|
2017
Q1 | $2.29M | Sell |
40,608
-157
| -0.4% | -$8.86K | 1.01% | 28 |
|
|
2016
Q4 | $2.11M | Buy |
40,765
+33,738
| +480% | +$1.74M | 0.93% | 34 |
|
|
2016
Q3 | $378K | Buy |
+7,027
| New | +$378K | 0.3% | 88 |
|